Rohto Pharmaceutical Co(MX:4527N)
MX$290.000.00 (0.00%)
MX:4527N
Rohto Pharmaceutical Co financials statements
MX$290.00
At close:0.00 (0.00%)
Rohto Pharmaceutical Co (4527N) Income Statement
0 Followers
Rohto Pharmaceutical Co Income Statement
Last quarter (Q2 2026), Rohto Pharmaceutical Co's total revenue was ¥82.29B, a decrease of 9.22% from the same quarter last year. In Q2, Rohto Pharmaceutical Co's net income was ¥5.88B. See Rohto Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|---|
| ¥ 308.63B | ¥ 343.73B | ¥ 270.84B | ¥ 238.66B | ¥ 199.65B | |
| ¥ 169.46B | ¥ 182.96B | ¥ 154.93B | ¥ 135.13B | ¥ 114.10B | |
| ¥ 131.00B | ¥ 142.25B | ¥ 114.77B | ¥ 101.59B | ¥ 86.24B | |
| Depreciation and Amortization | ¥ 13.14B | ¥ 17.38B | ¥ 8.69B | ¥ 7.80B | ¥ 7.69B |
| ¥ 56.42B | ¥ 65.48B | ¥ 50.40B | ¥ 42.34B | ¥ 35.81B | |
| ¥ 38.47B | ¥ 40.71B | ¥ 40.17B | ¥ 33.54B | ¥ 27.86B | |
| ¥ 3.87B | ¥ 6.12B | ¥ 1.35B | ¥ 752.00M | ¥ 16.00M | |
| ¥ 42.33B | ¥ 46.82B | ¥ 41.52B | ¥ 34.29B | ¥ 27.87B | |
| ¥ 31.00B | ¥ 34.25B | ¥ 30.94B | ¥ 26.38B | ¥ 21.13B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 136.11 | ¥ 151.56 | ¥ 135.60 | ¥ 115.62 | ¥ 92.61 |
| Diluted EPS | ¥ 135.44 | ¥ 145.29 | ¥ 135.21 | ¥ 115.29 | ¥ 92.34 |
| Weighted Average Shares Outstanding | 227.80M | 225.96M | 228.14M | 228.14M | 228.14M |
| Weighted Average Shares Outstanding (Diluted) | 228.90M | 235.46M | 228.80M | 228.80M | 228.80M |
Currency in JPY
